Teva developing new medicines to treat brain disorders -CEO

JERUSALEM, July 23 (Reuters) - Teva Pharmaceutical Industries expects to complete development of new medicines in the next few years aimed at treating brain disorders as the global population ages, its chief executive said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.